Stay updated on Bictegravir vs Dolutegravir in HIV/HepB Co-Infection Clinical Trial

Sign up to get notified when there's something new on the Bictegravir vs Dolutegravir in HIV/HepB Co-Infection Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Bictegravir vs Dolutegravir in HIV/HepB Co-Infection Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.2 to v3.8.0; the study record page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T16:12:20.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition from using “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T14:36:23.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-19T14:55:55.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label advances from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T15:17:48.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden message, blocking access to the study details and indicating that the page cannot be viewed at this time.
    Difference
    20%
    Check dated 2026-09-21T20:40:18.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    New revision v3.6.6 for the study protocol and SAP has been added, replacing the earlier v3.6.5. The updated documents are now available in the Study Documents section.
    Difference
    0.1%
    Check dated 2026-08-31T17:28:38.000Z thumbnail image

Stay in the know with updates to Bictegravir vs Dolutegravir in HIV/HepB Co-Infection Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Bictegravir vs Dolutegravir in HIV/HepB Co-Infection Clinical Trial page.